Andrew Guggenhime - Net Worth and Insider Trading
Andrew Guggenhime Net Worth
The estimated net worth of Andrew Guggenhime is at least $10 Million dollars as of 2024-12-01. Andrew Guggenhime is the PRESIDENT AND CFO of Vaxcyte Inc and owns about 109,491 shares of Vaxcyte Inc (PCVX) stock worth over $10 Million. Andrew Guggenhime is also the COO and CFO of Dermira Inc and owns about 5,116 shares of Dermira Inc (DERM) stock worth over $95,925. Details can be seen in Andrew Guggenhime's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Guggenhime has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Guggenhime
Andrew Guggenhime Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Guggenhime owns 5 companies in total, including Metacrine Inc (MTCR) , Vaxcyte Inc (PCVX) , and Dermira Inc (DERM) among others .
Click here to see the complete history of Andrew Guggenhime’s form 4 insider trades.
Insider Ownership Summary of Andrew Guggenhime
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MTCR | Metacrine Inc | 2020-09-15 | director |
PCVX | Vaxcyte Inc | 2024-11-18 | CFO & CBO |
DERM | Dermira Inc | 2020-02-20 | CFO |
2008-12-18 | SVP & Chief Financial Officer | ||
2021-07-22 | director |
Andrew Guggenhime Latest Holdings Summary
Andrew Guggenhime currently owns a total of 2 stocks. Among these stocks, Andrew Guggenhime owns 109,491 shares of Vaxcyte Inc (PCVX) as of November 18, 2024, with a value of $10 Million and a weighting of 99.08%. Andrew Guggenhime also owns 5,116 shares of Dermira Inc (DERM) as of November 9, 2016, with a value of $95,925 and a weighting of 0.92%.
Latest Holdings of Andrew Guggenhime
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PCVX | Vaxcyte Inc | 2024-11-18 | 109,491 | 94.34 | 10,329,381 |
DERM | Dermira Inc | 2016-11-09 | 5,116 | 18.75 | 95,925 |
Holding Weightings of Andrew Guggenhime
Andrew Guggenhime Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Guggenhime has made a total of 25 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 0 buys and 25 sells. The most-recent trade in Vaxcyte Inc is the sale of 8,000 shares on November 18, 2024, which brought Andrew Guggenhime around $686,480.
According to the SEC Form 4 filings, Andrew Guggenhime has made a total of 0 transactions in Dermira Inc (DERM) over the past 5 years. The most-recent trade in Dermira Inc is the sale of 4,100 shares on November 9, 2016, which brought Andrew Guggenhime around $143,582.
Insider Trading History of Andrew Guggenhime
- 1
Andrew Guggenhime Trading Performance
Andrew Guggenhime Ownership Network
Andrew Guggenhime Owned Company Details
What does Metacrine Inc do?
Who are the key executives at Metacrine Inc?
Andrew Guggenhime is the director of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .
Metacrine Inc (MTCR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Metacrine Inc Insider Transactions
Andrew Guggenhime Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Guggenhime. You might contact Andrew Guggenhime via mailing address: C/o Vaxcyte, Inc., 825 Industrial Road, Ste. 300, San Carlos Ca 94070.